Report cover image

Clinical Trials Feasibility Risk Assessment and Planning for Success - A Depression Case Study

Publisher GlobalData
Published Sep 26, 2023
Length 36 Pages
SKU # GBDT18252811

Description

Clinical Trials Feasibility Risk Assessment and Planning for Success - A Depression Case Study
Summary



This report provides the global clinical trial landscape for depression and identifies key analysis of the main features in order to run similar trials successfully.

As the prevalence of depression has increased, the outlook of it has also changed in positive ways. Better support and services for depression as well as the increase of discussing this order has lead to an increase of depression clinical trials. The COVID-19 pandemic has played a major role in that.

Key Highlights
  • COVID-19 pandemic has changed the landscape of depression clinical trials
  • Depression clinical trials are being ran all around the world, with North America having the most.
  • Top sponsors for depression trials are Eli Lilly and Massachusetts General Hospital.
  • The important of eliminating delays in depression clinical trials.
  • It is essential to select the right trial design, such as sites and investigators.
Scope
  • This report provides a review of global depression clinical trials derived from the GlobalData’s Clinical Trials Database and Feasibility Planner. The aim of this report is to provide analyses of these trials, coupled with analyses of what to expect when running a similar trial.
Reasons to Buy
  • Identifies and analyses depression clinical trials by multiple trial designs, such as trial start year, phase and virtual components.
  • Examines the effect of COVID-19 on depression trials
  • Gives reason for certain trends seen in depression trials
  • Uses the GlobalData's Feasibility Planner to help to improve trial planning
  • Comparison of enrollment parameters for different trials to an industry average
  • Provides analysis of best suited clinical trial sites and investigators for depression trials

Table of Contents

36 Pages
1 Table and Figures
List of Tables
List of Figures
2 Executive Summary
3 Introduction
Report Scope
Methodology
4 Global Depression Clinical Trial Landscape
2021 Was the Leading Year in Depression Clinical Trials
Phase I Has Dominated Depression Trials Since 2020
Single-Country Tops Multinational for Depression Trials
North America Has the Most Depression Clinical Trials
Non-industry Sponsors Lead Overall in Depression Trials
Eli Lilly Is the Top Industry Sponsor
Massachusetts General Hospital Tops Non-industry Sponsors
Phase IV Has the Longest Enrollment Period and Trial Duration
Two-Thirds of Depression Trials Have Achieved Endpoint Status
Decentralized Clinical Trial Used More in Depression Trials Due to the COVID-19 Pandemic
Mobile Healthcare and Telemedicine Used the Most in Decentralized Clinical Trials
5 Feasibility Planner - A Depression Case Study
Low Accrual Rate Is the Top Reason for Trial Termination in All Phases
Enrollment Rate Higher in Industry Average Compared to Five Trials
Number of Subjects and Sites Comparison of Five Trials to Industry Average
US Also Has the Most Recommended Sites for Depression Trials
Pennsylvania, US Is the Top Choice for Depression Clinical Trial Sites
US Has the Most Recommended Investigators for Depression Trials
6 Key Findings
7 Appendix
Abbreviations
About the Authors
About GlobalData
Contact Us
List of Tables
Table 1: Average Distance Travelled Between Top Five Sites for Depression Trials to the Top Five Sites by Disease Prevalence in the US
List of Figures
Figure 1: Number of Depression Clinical Trials, by Trial Start Year (2015-23)
Figure 2: Number of Depression Clinical Trials, by Trial Start Year and Phase
Figure 3: Number of Depression Clinical Trials by Phase, Single-Country Versus Multinational
Figure 4: Number of Depression Clinical Trials by Region and Phase
Figure 5: Number of Depression Clinical Trials by Phase, Industry Versus Non-industry
Figure 6: Depression Clinical Trials, by Top 10 Industry Sponsors
Figure 7: Depression Clinical Trials, by Top 10 Non-industry Sponsors
Figure 8: Projected Timelines for Depression Clinical Trials, by Phase
Figure 9: Endpoint Status for Depression Clinical Trials, by Phase
Figure 10: Number of Depression Trials Using Decentralized Virtual Components
Figures 11-12: Number of Depression Clinical Trials, by Virtual Components
Figure 13: Number of Depression Clinical Trials, by Trial Termination and Phase
Figure 14: Enrollment Rate Comparison
Figure 15: Number of Subjects and Sites Comparison
Figure 16: Top Recommended Sites for Depression Clinical Trials
Figure 17: Distance in Hours Between Top Five Sites for Depression Trials to the Top Five Sites by Disease Prevalence in the US
Figure 18: Top Recommended Investigator for Depression Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us